Literature DB >> 2723243

Oxygen free radicals and lungs.

A F Junod1.   

Abstract

Some of the metabolites resulting from the monovalent reduction of O2, superoxide anion and hydroxyl radical, are O2, radicals, whereas H2O2, which is not a radical since having no unpaired electron, is also an active O2 intermediate. These O2 metabolites are formed intracellularly as a result of normal metabolism. Their production can increase following exposure to high O2 concentration, radiations or certain drugs. An increased amount of extracellular O2 metabolites occurs after activation of certain inflammatory cells or during the course of the hypoxanthine-xanthine oxidase reaction. To counteract this oxidative stress, antioxidant defenses exist, whether enzymatic (superoxide dismutase, glutathione peroxidase, catalase, etc.) or nonenzymatic (GSH, vitamin E and C, etc.). Oxidative injury can result from an imbalance between oxidative stress and the defense mechanisms. The main targets are protein, DNA and lipids. The cellular response of the lung is stereotyped and involves cell injury (especially endothelial cells and type I pneumocytes), inflammatory reaction and repair processes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723243     DOI: 10.1007/BF00260878

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  16 in total

Review 1.  The response of the lung to foreign compounds that produce free radicals.

Authors:  L L Smith
Journal:  Annu Rev Physiol       Date:  1986       Impact factor: 19.318

Review 2.  Antioxidant defenses in the lung.

Authors:  I Fridovich; B Freeman
Journal:  Annu Rev Physiol       Date:  1986       Impact factor: 19.318

Review 3.  Oxy-radicals and related species: their formation, lifetimes, and reactions.

Authors:  W A Pryor
Journal:  Annu Rev Physiol       Date:  1986       Impact factor: 19.318

Review 4.  Pulmonary antioxidant defense mechanisms.

Authors:  C W White; J E Repine
Journal:  Exp Lung Res       Date:  1985       Impact factor: 2.459

Review 5.  Biology of disease: free radicals and tissue injury.

Authors:  B A Freeman; J D Crapo
Journal:  Lab Invest       Date:  1982-11       Impact factor: 5.662

6.  Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes.

Authors:  R B Fox; J R Hoidal; D M Brown; J E Repine
Journal:  Am Rev Respir Dis       Date:  1981-05

Review 7.  Oxygen-derived free radicals in postischemic tissue injury.

Authors:  J M McCord
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

8.  Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen.

Authors:  J D Crapo; B E Barry; H A Foscue; J Shelburne
Journal:  Am Rev Respir Dis       Date:  1980-07

9.  Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide.

Authors:  I U Schraufstatter; D B Hinshaw; P A Hyslop; R G Spragg; C G Cochrane
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

10.  Alterations in adenosine triphosphate and energy charge in cultured endothelial and P388D1 cells after oxidant injury.

Authors:  R G Spragg; D B Hinshaw; P A Hyslop; I U Schraufstätter; C G Cochrane
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

View more
  2 in total

1.  Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS.

Authors:  D Kietzmann; R Kahl; M Müller; H Burchardi; D Kettler
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

2.  Wedelolactone facilitates the early development of parthenogenetically activated porcine embryos by reducing oxidative stress and inhibiting autophagy.

Authors:  Xin-Qin Wang; Rong-Ping Liu; Jing Wang; Dan Luo; Ying-Hua Li; Hao Jiang; Yong-Nan Xu; Nam-Hyung Kim
Journal:  PeerJ       Date:  2022-07-25       Impact factor: 3.061

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.